Track topics on Twitter Track topics that are important to you
Building 227 Porton Down Science Park
Phone: 44 (0)1980 551320
Fax: 44 (0)1980 551321
UK gene cell therapy designer Oxford BioMedica’s shares jumped as much as 11.2% to 12.30 pence this…
Biopharmaceutical firm Axovant Sciences has agreed exclusive worldwide rights for the development and commercialisation of gene therapy company Oxford BioMedica’s...Read More... The post Axovant buy...
Innovate UK has awarded Oxford BioMedica a £3m grant to support the UK's efforts to produce viral vectors and ensure adequate supply to meet future demand.
Oxford BioMedica has been awarded a £3 million grant by the UK's innovation agency, Innovate UK, to support the UK's efforts to produce viral vectors and ensure adequate supply to meet future demand.
Bioverativ awarded a $100 million contract to the UK's Oxford BioMedica to develop lentiviral vectors for use in Bioverativ's -More-
Oxford BioMedica said today it will partner with Bioverativ to develop and manufacture lentiviral vectors designed to treat hemophilia, through a collaboration that could generate up to $105 million-p...
Oxford Biomedica intends to raise approximately £20.5m by way of a conditional placing of ordinary shares to raise money for expansion of bioprocessing facilities, the company said on Friday. The p.....
Oxford BioMedica will receive a US$5mln payment upfront and will be eligible to receive various milestone payments potentially worth in excess of US$100mln
Acolyte Biomedica Ltd provides rapid diagnostic systems for clinical microbiology. Acolyte's BacLite® platform allows microbial detection in hours instead of days, improving laboratory workflow, redu...
Oxford BioMedica advanced gene therapy techniques.
Boston Biomedica, Inc. is an infectious diseases management company providing products and services for the detection and treatment of infectious diseases (ID) such as AIDS, Lyme Disease, and Viral He...
Oxford BioMedica (LSE:OXB) is a leading gene and cell therapy group focused on developing life changing treatments for serious diseases. Oxford BioMedica and its subsidiaries (the...
The aCOLyte colony counter is available with two levels of functionality, Click’n’Count and SuperCount. Click'n'Count allows you to simply point to each colony and click to count. Click'n'Count ...
We have published hundreds of Acolyte Biomedica Ltd news stories on BioPortfolio along with dozens of Acolyte Biomedica Ltd Clinical Trials and PubMed Articles about Acolyte Biomedica Ltd for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Acolyte Biomedica Ltd Companies in our database. You can also find out about relevant Acolyte Biomedica Ltd Drugs and Medications on this site too.
Antiretroviral Therapy Clostridium Difficile Ebola HIV & AIDS Infectious Diseases Influenza Malaria Measles Sepsis Swine Flu Tropical Medicine Tuberculosis Infectious diseases are caused by pathogenic...